BIOSITE DIAGNOSTICS-TRIAGE PANEL FOR DRUGS ABUSE

Enzyme Immunoassay, Amphetamine

BIOSITE INCORPORATED

The following data is part of a premarket notification filed by Biosite Incorporated with the FDA for Biosite Diagnostics-triage Panel For Drugs Abuse.

Pre-market Notification Details

Device IDK914146
510k NumberK914146
Device Name:BIOSITE DIAGNOSTICS-TRIAGE PANEL FOR DRUGS ABUSE
ClassificationEnzyme Immunoassay, Amphetamine
Applicant BIOSITE INCORPORATED 11030 ROSELLE ST. San Diego,  CA  92121
ContactJohn F Bruni
CorrespondentJohn F Bruni
BIOSITE INCORPORATED 11030 ROSELLE ST. San Diego,  CA  92121
Product CodeDKZ  
CFR Regulation Number862.3100 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1991-09-16
Decision Date1991-10-11

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.